Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The potential therapeutic effects of THC on Alzheimer's disease.

Journal of Alzheimer's disease : JAD - 1 Jan 2014

Cao Chuanhai, Li Yaqiong, Liu Hui, Bai Ge, Mayl Jonathan, Lin Xiaoyang, Sutherland Kyle, Nabar Neel, Cai Jianfeng

Abstract excerpt

The purpose of this study was to investigate the potential therapeutic qualities of Δ9-tetrahydrocannabinol (THC) with respect to slowing or halting the hallmark characteristics of Alzheimer's disease. N2a-variant amyloid-β protein precursor (AβPP) cells were incubated with THC and assayed for amyloid-β (Aβ) levels at the 6-, 24-, and 48-hour time marks. THC was also tested for synergy with caffeine, in respect...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Peptides
Share to Amyloid beta-Protein Precursor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Respiration

Share to Enzyme-Linked Immunosorbent Assay

Share to Glycogen Synthase Kinase 3

Share to Glycogen Synthase Kinase 3 beta

Share to Neuroblastoma

Share to tau Proteins

Source

Identifiers

PMID: 25024327
DOI: 10.3233/JAD-140093

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The potential therapeutic effects of THC on Alzheimer's disease.PMID 25024327Read ↗

7-ketocholesterol enhances BACE1-amyloid precursor protein cleavage and amyloidogenic peptide generation targeted by natural moleculesSemantic proximity Read ↗

Exploring the anti-inflammatory activities, mechanism of action and prospective drug delivery systems of tocotrienol to target neurodegenerative diseasesSemantic proximity Read ↗

Cannabidiol in Neurology: Current Insights and Translational PerspectivesSemantic proximity Read ↗

Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesisSemantic proximity Read ↗

A new tacrine-melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer's disease.Semantic proximity Read ↗

Optimized turmeric extract reduces β-Amyloid and phosphorylated Tau protein burden in Alzheimer's transgenic mice.Semantic proximity Read ↗

Cannabinoid receptor CB2 ablation protects against TAU induced neurodegenerationSemantic proximity Read ↗

Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.Semantic proximity Read ↗

No significant effect of 7,8-dihydroxyflavone on APP processing and Alzheimer-associated phenotypes.Semantic proximity Read ↗

Investigating TRSV Phytoalexin Infusions as a Novel Treatment for Alzheimer’s Disease Using ApoE4 Plasmid Transfections in Neuro2a Cell ComplexesSemantic proximity Read ↗

Tacrine-6-Ferulic Acid, a Novel Multifunctional Dimer, Inhibits Amyloid-β-Mediated Alzheimer's Disease-Associated Pathogenesis In Vitro and In VivoSemantic proximity Read ↗

Camptothecin and its analogs reduce amyloid-β production and amyloid-β42-induced IL-1β production.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.